You can use it for nucleic acid extraction from biological tissues and for protein removal after enzymatic reactions of nucleic acids!
This product is a solution mixed with TE saturated phenol, chloroform, and isoamyl alcohol in a ratio of 25:24:1. It is used for nucleic acid extraction from biological tissues and for protein removal after enzymatic reactions of nucleic acids. Isoamyl alcohol helps reduce the foam generated during use. The TE saturated phenol (66% phenol) used has been pre-saturated with TE and contains 8-hydroxyquinoline. 【Features】 ■ TE saturated phenol (66% phenol) contains 8-hydroxyquinoline ■ Composition: 50(37)% TE saturated phenol, 48% chloroform, 2% isoamyl alcohol ■ It has two layers, with the upper layer being the TE layer for oxidation prevention, and the lower layer consisting of phenol/chloroform/isoamyl alcohol. *For more details, please refer to the related links or feel free to contact us.
Inquire About This Product
basic information
【Product Details】 ■Capacity: 250ml×1 ■Storage: 2–10℃ (light-protected) ■Container: Brown glass bottle *For more details, please refer to the related links or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Purpose】 ■Nucleic acid extraction from biological tissues, removal of proteins after enzymatic reactions of nucleic acids, etc. *For more details, please refer to the related links or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company is a product development-oriented enterprise that utilizes biotechnology. We develop and manufacture in vitro diagnostic pharmaceuticals (such as pregnancy tests and ovulation tests), diagnostic drugs for environmental, food, and animal and plant diseases, and reagents for genetic engineering research, using our expertise in gene and antibody technology. We hold manufacturing registration and manufacturing and sales licenses for both human and animal products, with over 30 years of experience in the manufacture of in vitro diagnostic pharmaceuticals. Additionally, we are engaged in personalized medicine, advancing research and development of diagnostic drugs using genetic polymorphism analysis and gene expression analysis.